Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-28

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nicardipine hydrochloride from Cipla USA Inc., indicating an update to this generic product's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)